Cipla Gains 3% on USFDA’s Final Approval for Lanreotide Injection
Cipla Ltd’s shares have gained 3 per cent to Rs 887.85 on the BSE in Monday’s intra-day trade after the company received the United States...
Use UNICORN Signals App
By EquityPandit
